Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study

Health and Quality of Life Outcomes

Fredrick Makumbi¹  Rhoda K Wanyenze³  Fred Wabwire-Mangen¹  Joseph KB Matovu²  Anne M Nabukenya² 

[1] Department of Epidemiology and Biostatistics, Makerere University School of Public Health, P.O Box 7062, Kampala, Uganda;MakSPH-CDC Fellowship Program, Makerere University School of Public Health, P.O. Box 7072, Kampala, Uganda;Department of Disease Control and Environmental Health, Makerere University School of Public Health, P.O Box 7062, Kampala, Uganda

关键词: QOLIE and health related quality of life;    Anti-epileptic drugs;    Seizures;    Epilepsy;   

Others  :  814982
DOI  :  10.1186/1477-7525-12-49

 received in 2013-10-31, accepted in 2014-04-08,  发布年份 2014

【 摘 要 】

Background

Epilepsy is a devastating disorder that impacts on patients’ quality of life, irrespective of use of anti epileptic drugs (AEDs). This study estimates the health-related quality of life (HRQOL) and its associated predictors among epilepsy patients receiving AEDs.

Methods

A total of 175 epilepsy patients already receiving AED for at least 3 months were randomly selected and interviewed from mental clinics at Mulago and Butabika national referral hospitals in Uganda between May - July 2011. A HRQOL index, the primary outcome, was constructed using items from Quality Of Life in Epilepsy Inventory (QOLIE-31) and the Hospital Anxiety and Depression Scale (HADS) questionnaires. The internal consistency and adequacy of these items was also computed using Cronbach's alpha and Kaiser-Meyer-Olkin tests. Partial correlations were used to evaluate the contribution of the health dimensions (mental, psychological, social, physical functioning and emotional well being) and, multiple linear regressions to determine factors independently associated with HRQOL.

Results

Just about half of the respondents (54%) were males, and nearly two thirds (62%) had received AEDs for at least 12 months. The average age was 26.6 years (SD = 11.1). The overall HRQOL mean score was 58 (SD = 13) on a scale of 0–100. The average scores of different dimensions or subscales ranged from 41 (physical) to 65 (psychological). At least three quarters (75%) of all subscales had good internal consistency and adequacy. The largest variations in the overall HRQOL were explained by social and mental functioning; each accounting for about 30% of the difference in the HRQOL but seizure control features explained a little (6%) variation. Factors negatively associated with HRQOL were poly-therapy (-1.16, p = 0.01) and frequency of seizures (-2.29, p = 0.00). Other factors associated with overall HRQOL included drug side effects, sex, marital status and education. Duration on AEDs was not a significant predictor of HRQOL.

Conclusion

The HRQOL for epilepsy patients on AEDs is very low. The predictors of low HRQOL were socio factors (marital status, education) and drug side effects, frequency of seizure, and type of therapy.

【 授权许可】

   
2014 Nabukenya et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D: Quality of life of people with epilepsy: a European study. Epilepsa 1997, 38(3):353-362.
• [2]Fisher RS, van Emde-Boas W, Blume W, Elger C, Genton P, Lee P, Engel J: Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46(4):470-472.
• [3]WHO: The Global Campaign against Epilepsy “Out of the Shadows, Epilepsy disease Fact Sheet No. 999. Geneva: Division of Mental Health; 2009. October 2010
• [4]Government of Uganda, Ministry of Health (MOH): Health sector strategic plan II 2005/06 – 2009/2010. http://siteresources.worldbank.org/INTPRS1/Resources/383606-1201883571938/Uganda_HSSP_2.pdf webcite
• [5]Zaccara G, Franciotta D, Perucca E: Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007, 48(7):1223-1244.
• [6]Elger CE, Schmidt D: Modern management of epilepsy: a practical approach. Epilepsy Behav 2008, 13(3):575.
• [7]Kwan P, Brodie MJ: Early identification of refractory epilepsy. N Engl J Med 2000, 342(5):314-319.
• [8]Gilliam F: Optimizing health outcomes in active epilepsy. Neurology 2002, 58(8 Suppl 5):S9-S20.
• [9]Jacoby A: Stigma, epilepsy, and quality of life. Epilepsy & Behav 2002, 3(6S2):10-20.
• [10]Johnson EK, Jones JE, Seidenberg S, Hermann BP: The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004, 45(5):544-550.
• [11]Cramer JA: Mood disorders are linked to health-related quality of life in epilepsy. Epilepsy & Behav 2002, 6(3):491-492.
• [12]Government of Uganda, Ministry of Health (MOH): Health sector strategic plan III, 2010/11-2014/15. http://www.health.go.ug/docs/HSSP_III_2010.pdf webcite
• [13]Tracy JI, Lippincott C, Mahmood T, Waldron B: Are depression and cognitive performance related in temporal lobe epilepsy? Epilepsia 2007, 48(12):2327-2335.
• [14]Vickrey BG, Berg AT, Sperling MR, Shinnar S: Relationships between seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia 2000, 41(6):760-764.
• [15]Cronbach LJ: Coeffecient Alpha and the Internal Structure of Tests, Psychometrika, 1951, 16(3). Am J Psychol 2002, 57:360-361.
• [16]Jackson JE: A User's Guide to Principal Componets. Newyork: Willy; 2003.
• [17]Babikako HM, Neuhauser D, Katamba A, Mupere E: Feasibility, reliability and validity of health-related quality of life questionnaire among adult pulmonary tuberculosis patients in urban Uganda: cross-sectional study. Health Qual Life Outcome 2010, 8(93):1477-7525.
• [18]Mast TC, Kigozi G, Wabwire-mangen F, Black F: Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care 2004, 16(1):81-94.
• [19]Trimble MR, Dodson WE: Epilepsy and quality of life. New York: Raven Press; 1994.
• [20]Valeria E, Bravi F, Turner K: Health-related quality of life in adults with epilepsy: the effect of age, age at onset and duration of epilepsy in a multicentre Italian study. BMC Neurology 2011, 11:33. BioMed Central Full Text
• [21]Jacoby A, Baker GA: Quality-of-life trajectories in epilepsy: a review of the literature. Epilepsy Behav 2008, 12(4):557-561.
• [22]WHO: The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995, 41(10):1403-1409.
• [23]Aydemir N, Snape D: Multiple impacts of epilepsy and contributing factors: findings from an ethnographic study in Vietnam. Epilepsy Behav 2009, 16(3):512-520.
• [24]Thomas SV, Sudhakaran Nair CR: Frequent seizures and polytherapy can impair quality of life in persons with epilepsy. Neurol India 2005, 53(1):46-50.
• [25]Sisodiya SM, Marini C: Genetics of antiepileptic drug resistance. Curr Opin Neurol 2009, 22(2):150-156.
• [26]Haag A, Bauer S: Quality of life and employment status are correlated with antiepileptic monotherapy versus polytherapy and not with use of "newer" versus "classic" drugs: results of the "Compliant 2006" survey in 907 patients. Epilepsy Behav 2010, 19(4):618-622.
• [27]Livanainen M, Eldridge R: Effect of phenytoin on the mental and physical function of patients with Baltic myoclonus epilepsy. Ital J Neurol Sci 1987, 8(4):313-317.
• [28]Baker GA: The psychosocial burden of epilepsy. Epilepsia 2002, 43(s6):26-30.